首页 文献索引 SCI期刊 AI助手
条件筛选
相关性 最新发表 最早发表
全文 标题 期刊 作者
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
模糊 精准
{{tag.shortname||tag.name}}:{{getFilterLabel(field)}} Clear All
Jürgen Ordemann,Ulf Elbelt Jürgen Ordemann
This article highlights the effects of these both treatment approaches on body weight, cardiometabolic risk factors and long-term prognosis, particularly with respect to cardiovascular events and remission of type 2 diabetes.
Flavio T Vieira,Camila E Orsso,Jenneffer R B Tibaes et al. Flavio T Vieira et al.
We aimed to examine associations of DD with lifestyle behaviors and cardiometabolic risk factors in adolescents with obesity. Methods: This is a secondary analysis of a cross-sectional study.
Paul Horn,Frank Tacke Paul Horn
Lifestyle interventions (eg, weight reduction, Mediterranean diet, exercise, alcohol abstinence) and the treatment of cardiometabolic risk factors continue to be the mainstay of treatment and prevention of the disease.
Brandon M Kistler,Danielle L Kirkman,Dave Kusni et al. Brandon M Kistler et al.
This narrative Review will outline the evidence for the effects of physical activity and exercise type on cardiometabolic risk factors in adults and provide insights for patients and clinicians.
Katrina Pekarska,Laura Burke,Ian Rowe et al. Katrina Pekarska et al.
Background and aims: Steatotic liver disease (SLD) describes a spectrum of liver disease caused by cardiometabolic risk factors (CMRF) and/or alcohol.
Eric J Brandt,Cindy W Leung,Tammy Chang et al. Eric J Brandt et al.
Background: Naturally occurring dietary patterns are not well described among individuals with cardiovascular disease (CVD) or cardiometabolic risk factors (i.e., diabetes, hypertension, obesity, and dyslipidemia), particularly considering socioeconomic vulnerability.
Valeria Grancini,Irene Cogliati,Gianfranco Alicandro et al. Valeria Grancini et al.
Introduction: Data about efficacy and safety of GLP1 receptor agonists in liver-transplanted patients are lacking. Methods: Among a pop...
Huiyul Park,Terry Cheuk-Fung Yip,Eileen L Yoon et al. Huiyul Park et al.
Background & aims: Evaluating five cardiometabolic risk factors (CMRFs) is crucial for diagnosing metabolic dysfunction-associated steatotic liver disease (MASLD)....Impact and implications: Understanding the impact of the five cardiometabolic risk factors (CMRFs) used in the diagnosis of metabolic dysfunction-associated steatotic liver disease (MASLD) on hepatic fibrosis and long-term clinical outcomes can improve the quality of care in the general
Jun-Wei Ren,Jia-Hao Wang,Yun-Fei Xiao et al. Jun-Wei Ren et al.
Circadian syndrome (CircS), a cluster of cardiometabolic risk factors related to circadian disruption, may interact with these conditions, but evidence remains limited.
Mads Israelsen,Eric Trépo,Aleksander Krag et al. Mads Israelsen et al.
Metabolic and alcohol-related liver disease (MetALD) is a subcategory of steatotic liver disease (SLD) characterized by the coexistence of cardiometabolic risk factors and elevated alcohol intake.
耗时 0.13966 秒,为您在 48223910 条记录里面共找到 3989 篇文章 [XML]